annual working capital:
$526.80M+$181.83M(+52.71%)Summary
- As of today (July 4, 2025), RXRX annual working capital is $526.80 million, with the most recent change of +$181.83 million (+52.71%) on December 31, 2024.
- During the last 3 years, RXRX annual working capital has risen by +$38.74 million (+7.94%).
- RXRX annual working capital is now at all-time high.
Performance
RXRX Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$442.16M-$84.63M(-16.07%)Summary
- As of today (July 4, 2025), RXRX quarterly working capital is $442.16 million, with the most recent change of -$84.63 million (-16.07%) on March 31, 2025.
- Over the past year, RXRX quarterly working capital has increased by +$172.47 million (+63.95%).
- RXRX quarterly working capital is now -28.46% below its all-time high of $618.10 million, reached on June 30, 2021.
Performance
RXRX quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
RXRX Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +52.7% | +64.0% |
| 3 y3 years | +7.9% | -17.2% |
| 5 y5 years | +655.6% | - |
RXRX Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.7% | -16.1% | +64.0% |
| 5 y | 5-year | at high | +655.6% | -28.5% | +126.8% |
| alltime | all time | at high | +655.6% | -28.5% | +126.8% |
RXRX Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $442.16M(-16.1%) |
| Dec 2024 | $526.80M(+52.7%) | $526.80M(+44.2%) |
| Sep 2024 | - | $365.28M(-16.3%) |
| Jun 2024 | - | $436.29M(+61.8%) |
| Mar 2024 | - | $269.69M(-21.8%) |
| Dec 2023 | $344.97M(-26.5%) | $344.97M(+9.0%) |
| Sep 2023 | - | $316.40M(-0.2%) |
| Jun 2023 | - | $317.06M(-20.7%) |
| Mar 2023 | - | $399.98M(-14.8%) |
| Dec 2022 | $469.55M | $469.55M(+17.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $398.58M(-11.3%) |
| Jun 2022 | - | $449.34M(-15.8%) |
| Mar 2022 | - | $533.75M(+9.4%) |
| Dec 2021 | $488.06M(+100.6%) | $488.06M(-12.5%) |
| Sep 2021 | - | $557.93M(-9.7%) |
| Jun 2021 | - | $618.10M(+217.0%) |
| Mar 2021 | - | $194.97M(-19.9%) |
| Dec 2020 | $243.34M(+249.1%) | - |
| Dec 2020 | - | $243.34M |
| Dec 2019 | $69.71M | - |
FAQ
- What is Recursion Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual working capital year-on-year change?
- What is Recursion Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly working capital year-on-year change?
What is Recursion Pharmaceuticals annual working capital?
The current annual working capital of RXRX is $526.80M
What is the all time high annual working capital for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual working capital is $526.80M
What is Recursion Pharmaceuticals annual working capital year-on-year change?
Over the past year, RXRX annual working capital has changed by +$181.83M (+52.71%)
What is Recursion Pharmaceuticals quarterly working capital?
The current quarterly working capital of RXRX is $442.16M
What is the all time high quarterly working capital for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly working capital is $618.10M
What is Recursion Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, RXRX quarterly working capital has changed by +$172.47M (+63.95%)